Atlas Trials

Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis

Clinical trial NCT02821689 · UNKNOWN

Trial details

NCT number
NCT02821689
Sponsor
RenJi Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
DermatopolymyositisInterstitial Lung Disease
Start date
2016-07-01
Primary completion
2017-06-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.